Sanofi-Regeneron's arthritis drug sarilumab enters late-stage trials

05/15/2013 | Yahoo

Sanofi and Regeneron Pharmaceuticals have started enrolling patients with moderate to severe rheumatoid polyarthritis for two late-stage trials of their experimental drug sarilumab. The partners intend to recruit 2,600 patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX